SETD1A-SOX2 axis is involved in tamoxifen resistance in estrogen receptor α-positive breast cancer cells

Rationale: Approximately 30-40% of estrogen receptor (ER)-positive breast cancer (BC) cases recur after tamoxifen therapy. Thus, additional studies on the mechanisms underlying tamoxifen resistance and more specific prognostic biomarkers are required. In this study, we investigated the role of the S...

Descripción completa

Detalles Bibliográficos
Autores principales: Jin, Ming Li, Yang, Liu, Jeong, Kwang Won
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373809/
https://www.ncbi.nlm.nih.gov/pubmed/35966598
http://dx.doi.org/10.7150/thno.72599

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9373809/
https://www.ncbi.nlm.nih.gov/pubmed/35966598
http://dx.doi.org/10.7150/thno.72599

Ejemplares similares